RAPPRapport Therapeutics Inc. Common Stock
48.24USD-1.69%Mkt Cap: 2.31B $P/E: —3d ago
Rapport Therapeutics, Inc., operates as a clinical-stage biopharmaceutical company that focuses on the discovery and development of transformational small molecule medicines for patients suffering from central nervous sy…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap2.31B $
Enterprise Value1.87B $
Revenue (TTM)20.00M $
Gross Profit-21.88M $
Net Income (TTM)-111.48M $
Revenue/Share0.4450 USD
Last Price48.24 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees84
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-9.15
PEG—
EV/EBITDA-12.26
EV/Revenue93.49
P/S114.79
P/B5.43
EPS (TTM)-2.96
EPS (Forward)-5.23
52W Range
13.8695% of range49.90
52W High49.90 USD
52W Low13.86 USD
Profitability
Gross Margin-109.39%
Oper. Margin-767.58%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-23.00%
ROA-21.76%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-87.47M $
CapEx (TTM)616.00K $
FCF Margin-280.08%
FCF Yield-2.42%
Net Debt-425.97M $
Net Debt/EBITDA2.79
Balance Sheet
Debt/Equity0.02
Current Ratio15.72
Quick Ratio15.35
Book Value/Sh8.819 USD
Cash/Share9.089 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.1 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)62.05 USD
Upside (mean)+28.6%
Target Range50.00 USD – 80.00 USD
$50.00+28.6% to mean$80.00
# Analysts12
Ownership
Shares Out.47.98M
Float32.30M
Insiders4.47%
Institutions108.71%
Short Interest
Short Ratio6.0d
Short % Float7.42%
Short % Out.4.69%
Shares Short2.25M
Short (prev mo.)2.26M
Technical
SMA 5041.80 (+15.4%)
SMA 20033.51 (+44.0%)
Beta0.97
S&P 52W Chg18.16%
Avg Vol (30d)289.70K
Avg Vol (10d)263.06K
Technical Indicators
RSI (14)63.5
MACD2.1630
MACD Signal1.8470
MACD Hist.+0.3160
BB Upper51.00 USD
BB Middle44.61 USD
BB Lower38.22 USD
BB Width28.66%
ATR (14)2.220 USD
Vol Ratio (20d)0.51x